• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Board Meeting, 04-11-2025: Outcome of Board Meeting

    04-11-2025 | 02:33 pm

    Alembic Pharma's Board approved Q2 & H1 FY26 consolidated financial results. Revenue from ops hit ₹1,910.15 Cr, with profit at ₹184.71 Cr for the quarter. The company also acquired a UK R&D entity for ₹221.97 Cr in Q2, boosting intangible assets.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited